Dynavax Technologies Corp. (DVAX)

$ 9.59
   
  • Change Today:
    $-0.10
  • 52 Week High: $14.40
  • 52 Week Low: $9.36
  • Currency: US Dollars
  • Shares Issued: 65.06m
  • Volume: 1,351,126
  • Market Cap: $623.96m
  • RiskGrade: 699

DVAX Overview

1 Day Chart (23-09-2025)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

DVAX Fundamentals

Fundamentals data is not available for this company.

DVAX Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 334.95 3.69 (37.24)¢ n/a n/a n/a n/a 0.0%
31-Dec-26 390.46 60.69 41.29¢ 23.2 n/a n/a n/a 0.0%
31-Dec-27 450.61 74.79 59.87¢ 16.0 0.4 +45% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

DVAX ShareCast News

No recent information was found.

DVAX Top Newspaper Links

Dynavax, Merck team up on hepatitis B vaccine 02-Nov-2007 BayArea.com
Merck Buys License to Sell New Vaccine for Hepat... 01-Nov-2007 New York Times
Business Digest 20-Jan-2006 BayArea.com

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

DVAX Market Data

Currency US Dollars
Share Price $ 9.59
Change Today $ -0.10
% Change -1.03 %
52 Week High $14.40
52 Week Low $9.36
Volume 1,351,126
Shares Issued 65.06m
Market Cap $623.96m
RiskGrade 699

What The Brokers Say

Strong Buy 1
Buy 4
Neutral 0
Sell 1
Strong Sell 0
Total 6
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2025

Time Volume / Share Price
0 @ $0.00

Top of Page